Category Archives: Reissue

In re Rosuvastatin Calcium Patent Litigation – Making “Therasense” out of Confusion

Recently, a divided three judge panel sorting out a multi-party Hatch-Waxman suit, ruled that the patentee, Shinonogi, had not committed inequitable conduct in obtaining the patent that was subsequently reissued so as to obtain narrow claims focused on Rosuvastatin, or … Continue reading

Posted in Inequitable Conduct/Rule 56, Reissue | Tagged , , , , , , , , , , , , , , , , | 1 Comment